GENEVA, Oct. 1 -- SAMYANG BIOPHARM CORPORATION filed a patent application (KR2026/095095) for “NANOPARTICLE COMPOSITION FOR LUNG-SELECTIVE DRUG DELIVERY”. With publication no. WO/2026/192441, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/51
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....